Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liraglutide”

379 trials

Showing 20 of 379 results

Not applicableStudy completedNCT01460069
What this trial is testing

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Who this might be right for
Psoriasis
Annesofie Faurschou 20
Large-scale testing (Phase 3)Study completedNCT01179048
What this trial is testing

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9,341
Large-scale testing (Phase 3)Study completedNCT01676116
What this trial is testing

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 438
Not applicableStudy completedNCT04190160
What this trial is testing

Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

Who this might be right for
Type2 Diabetes
Stefano Rizza 35
Not applicableLooking for participantsNCT06720246
What this trial is testing

Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity

Who this might be right for
Obesity and Overweight
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 50
Early research (Phase 1)Study completedNCT01511185
What this trial is testing

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 20
Post-approval studies (Phase 4)Study completedNCT01795248
What this trial is testing

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

Who this might be right for
Gestational Diabetes Mellitus
Tina Vilsboll 105
Large-scale testing (Phase 3)Study completedNCT02505334
What this trial is testing

A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 635
Large-scale testing (Phase 3)Study completedNCT01664247
What this trial is testing

The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 346
Post-approval studies (Phase 4)UnknownNCT03883412
What this trial is testing

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

Who this might be right for
Type2 Diabetes
University of Virginia 60
Early research (Phase 1)Study completedNCT01511692
What this trial is testing

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 43
Early research (Phase 1)Study completedNCT01620476
What this trial is testing

Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 24
Post-approval studies (Phase 4)Study completedNCT01664676
What this trial is testing

Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
University of Aarhus 11
Post-approval studies (Phase 4)Study completedNCT02545738
What this trial is testing

Antiproteinuric Effects of Liraglutide Treatment

Who this might be right for
Diabetic Kidney Disease
Steno Diabetes Center Copenhagen 32
Not applicableStudy completedNCT03885297
What this trial is testing

3mg Liraglutide for Overweight or Obesity

Who this might be right for
OverweightObesityInfertility, Female
University Hospitals Coventry and Warwickshire NHS Trust 43
Early research (Phase 1)Study completedNCT01507389
What this trial is testing

Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 24
Very early researchStudy completedNCT01856790
What this trial is testing

Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Jennifer Sherr 15
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Post-approval studies (Phase 4)Study completedNCT04881110
What this trial is testing

Liraglutide and Peripheral Artery Disease

Who this might be right for
Type 2 DiabetesPeripheral Arterial Disease
University of Campania Luigi Vanvitelli 60
Early research (Phase 1)Study completedNCT01511159
What this trial is testing

Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 32
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation